Core Concepts
Universal monovalent COVID vaccines are recommended by the CDC to prevent severe outcomes and protect against the mutating virus.
Abstract
The CDC's Advisory Committee on Immunization Practices backed the authorization of new monovalent COVID vaccines to combat rising hospitalizations and deaths due to COVID-19. The committee voted nearly unanimously in favor of universal XBB-containing shots. Key highlights include the robust benefits of vaccination in preventing deaths and long-term risks from COVID, concerns about declining vaccination rates and rising hospitalizations, and the importance of a universal recommendation to clarify vaccination guidelines. The committee also discussed the need to focus on at-risk groups and the hope that a universal mandate would improve access to vaccines for the uninsured.
Stats
Reports of about 17,000 COVID hospitalizations per week in the US
Close to 153 million doses of last year's bivalent booster administered in the US
Quotes
"We have more tools than ever to prevent the worst outcomes from COVID-19." - CDC director Mandy Cohen, MD, MPH
"I'm astonished by the number of people who are not vaccinated. We need a universal recommendation to add clarity for people." - Camille Nelson Kotton, MD